Primary links
about
our goal
governance
our company
our values
careers
history
awards
product
pipeline
infectious disease
oncology
autoimmunity
technologies
SMIP
SCORPION
MVAtor
clinical
active trials
completed trials
clinical trial resources
investigators & CROs
partnering
acquisitions
collaboration opportunities
SMIP
ES301
X1
SCORPION
X1
X2
T-Scorp
outlicensing
alliances
product development partnerships
government relationships
investors
governance
news
financial information
SEC filings
events
stock information
careers
life @ emergent
our people
how we work
our culture
grow with us
benefits
incentive compensation
recognition awards
employee referral program
job opportunities
newsroom
press releases
featured stories
videos
contacts
contact us
Financial Information
Fundamentals
Financial Reports
Quarterly Results
Investor Toolkit
Print Page
Email Page
RSS Feeds
Email Alerts
Financial Tear Sheet
Online Investor Kit
Investor FAQs
Information Request
Follow @emergentbiosolu
<<
Back
5 Year EPS Growth (%)
This growth rate is the compound annual growth rate of Earnings Per Share Excluding Extraordinary Items and Discontinued Operations over the last 5 years.
AT-A-GLANCE
Governance
News
Financial Information
SEC Filings
Events
Stock Information